Chordate Medical Holding AB (publ) (CMH.ST)
SEK 12.6
(-1.18%)
SEK 12.6
(-1.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 976.28 Thousand | 108.51 Thousand | 882.04 Thousand | 618 Thousand | 1.16 Million | 945.11 Thousand |
| Cost of Revenue | 29.39 Million | 74.45 Thousand | -1.04 Million | -1.89 Million | -907.71 Thousand | 991.35 Thousand |
| Gross Profit | -28.41 Million | 34.06 Thousand | 1.92 Million | 2.51 Million | 2.07 Million | -46.23 Thousand |
| Operating Expenses | 1.3 Million | 28.05 Million | 23.66 Million | 21.93 Million | 26.61 Million | 26.58 Million |
| Selling, General and Administrative Expenses | -29.57 Million | 19.83 Million | 16.46 Million | 13.68 Million | 17.88 Million | 14.66 Million |
| Research and Development Expenses | 1.21 Million | 1.21 Million | 304.06 Thousand | 1.2 Million | 3.6 Million | 3.6 Million |
| Other Expenses | 29.66 Million | 8.22 Million | 7.2 Million | 8.24 Million | 8.72 Million | 11.92 Million |
| Cost and Expenses | 30.6 Million | 28.13 Million | 22.62 Million | 20.03 Million | 25.7 Million | 27.58 Million |
| Operating Income | -29.57 Million | -28.02 Million | -21.74 Million | -19.42 Million | -24.54 Million | -26.62 Million |
| Interest Expense | 6684.00 | - | 24.88 Thousand | 338.27 Thousand | 346.77 Thousand | 473.82 Thousand |
| Income Tax Expense | - | -81.15 Thousand | 24.88 Thousand | 338.27 Thousand | 346.77 Thousand | -408.63 Thousand |
| Earnings before Tax | -29.18 Million | -27.94 Million | -21.76 Million | -19.75 Million | -24.88 Million | -26.68 Million |
| Net Income | -29.18 Million | -27.94 Million | -21.76 Million | -19.75 Million | -24.88 Million | -26.68 Million |
| Earnings Per Share Basic | -0.13 | -67.28 | -0.13 | -108.56 | -233.49 | -674.46 |
| Earnings Per Share Diluted | -0.13 | -67.28 | -0.13 | -108.56 | -233.49 | -674.46 |
| Weighted Average Shares Outstanding | 224.51 Million | 415.32 Million | 171.96 Million | 182.01 Million | 106.59 Million | 39.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 224.51 Million | 415.32 Million | 171.96 Million | 182.01 Million | 106.59 Million | 39.56 Million |
| Gross Margin | -29.10 | 0.31 | 2.18 | 4.07 | 1.78 | -0.05 |
| EBIT Margin | -28.62 | -235.64 | -22.90 | -27.27 | -16.27 | -19.64 |
| Profit Margin | -29.90 | -257.50 | -24.68 | -31.97 | -21.39 | -28.24 |
| EBITDA | -27.94 Million | -26.78 Million | -20.5 Million | -18.05 Million | -22.53 Million | -18.15 Million |
| Earnings Before Tax Margin | -30.29 | -258.25 | -24.65 | -31.42 | -21.09 | -28.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 172.94 Thousand | 257.67 Thousand | 481.59 Thousand | 976.28 Thousand | 210.94 Thousand | 163.31 Thousand |
| Cost of Revenue | -896.61 Thousand | 6.27 Million | 10.49 Million | 30.6 Million | -298.07 Thousand | -236.56 Thousand |
| Gross Profit | 1.06 Million | -6.01 Million | -10 Million | -29.63 Million | 509.02 Thousand | 399.88 Thousand |
| Operating Expenses | 8.2 Million | 6.61 Million | 10.31 Million | 30.88 Million | 5.6 Million | 7.75 Million |
| Selling, General and Administrative Expenses | - | 6.03 Million | 9.7 Million | - | 5.11 Million | 5.79 Million |
| Research and Development Expenses | - | - | 1.21 Million | - | - | - |
| Other Expenses | 8.2 Million | -1.00 | 2.00 | -4.00 | - | - |
| Cost and Expenses | 7.3 Million | 6.27 Million | 10.49 Million | 30.6 Million | 5.31 Million | 7.51 Million |
| Operating Income | -7.13 Million | -6.01 Million | -10 Million | -29.63 Million | -5.1 Million | -7.35 Million |
| Interest Expense | - | - | - | 6684.00 | - | - |
| Income Tax Expense | - | 1.00 | 3.00 | -3.00 | 652.89 Thousand | 491.77 Thousand |
| Earnings before Tax | -7.02 Million | -6.01 Million | -9.84 Million | -29.18 Million | -4.93 Million | -7.29 Million |
| Net Income | -7.02 Million | -6.01 Million | -9.84 Million | -29.18 Million | -4.93 Million | -7.29 Million |
| Earnings Per Share Basic | -0.01 | -9.23 | -16.08 | - | -8.07 | -11.91 |
| Earnings Per Share Diluted | -0.01 | -9.23 | -16.08 | - | -8.07 | -11.91 |
| Weighted Average Shares Outstanding | 980.22 Million | 652.32 Million | 612.04 Million | 612.04 Thousand | 612.04 Million | 612.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 980.22 Million | 652.32 Million | 612.04 Million | 612.04 Thousand | 612.04 Million | 612.04 Million |
| Gross Margin | 6.18 | -23.35 | -20.78 | -30.35 | 2.41 | 2.45 |
| EBIT Margin | -38.04 | -21.19 | -19.51 | - | -21.27 | -41.27 |
| Profit Margin | -40.61 | -23.36 | -20.44 | -29.90 | -23.41 | -44.65 |
| EBITDA | -6.57 Million | -5.46 Million | -9.39 Million | - | -4.48 Million | -6.73 Million |
| Earnings Before Tax Margin | -41.25 | -23.35 | -20.78 | -30.35 | -24.18 | -45.02 |
COVTY
688378
OVTZ
HARVIA
3708
VASO